BIOCRYST PHARMACEUTICALS, INC.: accounts_receivable
| Value | {"amount": 5642000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2020-03-31) |
| Status | current |
| Entity | BIOCRYST PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:48:48.725352+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/c46c2f57-7011-4f00-9b10-02b5b313314b
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001171843-20-003557Retrieved: 2026-08-19T08:48:48.725352+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000882796/accounts-receivable/2020-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/c46c2f57-7011-4f00-9b10-02b5b313314b
History
- no predecessors — first report